4ET-15191-08899 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-26
Dose 1 — Pfizer-BioNTech
2022-07-01
Registered in v-safe
2022-07-01
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-02
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-07
Health check-in — day 7, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-10
Health check-in — day 14, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-17
Survey response — day 21, dose 1, under 3
MedDRA: Diarrhoea, Pyrexia, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Febrile illness, diarrhea, runny nose

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-06-26	Pfizer-BioNTech	No

Free text

Release 12 (Under 3) — day 21, dose 1, under 3

2022-07-17

Symptoms: Febrile illness, diarrhea, runny nose

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Diarrhoea	·	·	✓
SD	Pyrexia	·	·	✓
SD	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release